Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$8.38 USD
+0.33 (4.10%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $8.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Earnings News For AMRX
-
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates
-
Amneal: Q2 Earnings Snapshot
-
Amneal Reports Second Quarter 2024 Financial Results
-
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
-
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
-
Amneal: Q1 Earnings Snapshot
-
Amneal Reports First Quarter 2024 Financial Results
-
Amneal: Q4 Earnings Snapshot
-
Amneal: Q4 Earnings Snapshot
-
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates
-
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
-
Amneal: Q3 Earnings Snapshot
-
Amneal Reports Third Quarter 2023 Financial Results
-
Amneal Pharmaceuticals (AMRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial Guidance
-
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates
-
Amneal Reports Second Quarter 2023 Financial Results
-
Amneal: Q1 Earnings Snapshot
-
Amneal Reports First Quarter 2023 Financial Results
-
Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for
-
Amneal Reports Certain Preliminary First Quarter 2023 Financial Results and Affirms Full Year 2023 Financial Guidance
-
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates
-
Amneal: Q4 Earnings Snapshot
-
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results
-
Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Lag Estimates